GGrantIndex
Sort

326,823 grants matching clinical trial

ADULT AIDS CLINICAL TRIALS UNIT

$1,569,878
Duke University · U01 · FY2002 · AI

Proteases in Cancer Biology and Drug Development

$1,569,832
Zena Werb · University Of California, San Francisco · P01 · FY2007 · CA

Defining the mechanisms of HIV resistance to bNAbs in humans

$1,569,774
Marina Caskey · Rockefeller University · U01 · FY2024 · AI

Defining the mechanisms of HIV resistance to bNAbs in humans

$1,569,774
Marina Caskey · Rockefeller University · U01 · FY2022 · AI

Defining the mechanisms of HIV resistance to bNAbs in humans

$1,569,774
Marina Caskey · Rockefeller University · U01 · FY2025 · AI

Defining the mechanisms of HIV resistance to bNAbs in humans

$1,569,774
Marina Caskey · Rockefeller University · U01 · FY2023 · AI

ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU

$1,569,766
University Of Puerto Rico Med Sciences · U01 · FY2005 · AI

Clinical Training in Rheumatology

$1,569,712
James Katz · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIE · FY2021 · AR

Progesterone in Brain Aging and Alzheimer's Disease

$1,569,557
Roberta Diaz Brinton · University Of Southern California · P01 · FY2006 · AG

Peruvian/Brazilian Amazon Center of Excellence in Malaria

$1,569,556
Joseph M. Vinetz · University Of California, San Diego · U19 · FY2013 · AI

NINDS Cooperative Program in Translational Research

$1,569,553
Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2012 · NS

Development of Toll-Like Receptor Agonists as Neuroprotectants in Brain Ischemia

$1,569,553
Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2012 · NS

The first clinical use of the BiVACOR Total Artificial Heart

$1,569,477
Daniel Timms · Bivacor, Inc. · R44 · FY2023 · HL

Optimizing Recovery and Preservation of Endogenous Insulin Secretion

$1,569,437
Steven E Kahn · Seattle Inst For Biomedical/Clinical Res · U01 · FY2014 · DK

Trial to Assess Chelation Therapy 2 (TACT2) DCC

$1,569,420
Kevin J Anstrom · Duke University · UH3 · FY2018 · AT

Modifications to improve HIV neutralizing antibodies

$1,569,354
John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Early Phase Clinical Cancer Prevention Consortium

$1,569,332
Dean E. Brenner · University Of Michigan At Ann Arbor · UG1 · FY2021 · CA

Mitochondrial Encephalomyopathies and Mental Retardation

$1,569,268
Salvatore Dimauro · Columbia University Health Sciences · P01 · FY2008 · HD

Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit

$1,568,808
Jeffrey S Stringer · Univ Of North Carolina Chapel Hill · UM1 · FY2012 · AI

Center for Prevention and Early Intervention

$1,568,732
Nicholas S Ialongo · Johns Hopkins University · P30 · FY2013 · MH

Clinical Center for Look AHEAD: Health in Diabetes

$1,568,720
University Of Pennsylvania · U01 · FY2002 · DK

TITLE: SUB POPULATIONS AND INTERMEDIATE OUTCOMES MEASURES IN COPD STUDY (SPIROMICS) - GENOMICS & INFORMATICS CENTER

$1,568,651
David Couper · Univ Of North Carolina Chapel Hill · N01 · FY2016 · HL

Clinical Islet Transplantation: Data Coordinating Center

$1,568,635
William R Clarke · University Of Iowa · U01 · FY2011 · DK

Penn prevention clinical trials unit

$1,568,547
David S Metzger · University Of Pennsylvania · U01 · FY2008 · AI

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)

$1,568,477
Rajiv Panikkar · Geisinger Clinic · UG1 · FY2022 · CA